Topoisomerase II Alpha Novocastra
Topoisomerase II alpha is an essential nuclear enzyme involved in DNA replication and is a target for many anti-cancer drugs used for cancer therapy. Decreased expression of topoisomerase II alpha is the predominant mechanism of resistance to several chemotherapeutic agents. A significant variation in the range of expression of this protein has been reported in many different tumors. Reports of the analysis of primary breast tumors have indicated that topoisomerase II beta is more widely expressed than topoisomerase II alpha. Topoisomerase II alpha expression and activity is linked to the cell cycle and is associated with the proliferation status of cells.
Request a quote
|TOPOIIA-L-U||1ml NCL-L-TOPOIIA||Liquid Concentrated Monoclonal Antibody||P(HIER)||Info||MSDS||
|TOPOIIA-U||1ml NCL-TOPOIIA US IVD||Lyophilised Concentrated Monoclonal Antibody||F, P(HIER), W||Info||MSDS||
|TOPOIIA-S||0.1ml NCL-TOPOIIA||Lyophilised Concentrated Monoclonal Antibody||F, P(HIER), W||Info||MSDS||